TECHNE CORPORATION
HomeCompany NewsFinancial InformationAbout TechneMap - DirectionsProductsContact Us

Segment Results - 4th Quarter Fiscal Year 2004

TECHNE CORPORATION AND SUBSIDIARIES
(in thousands of $’s, except per share data)

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
  First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD Percent
Of Sales
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD
Sales 37,993 38,264 42,541 42,459 161,257 100% 3,445 4,964 4,804 3,033 16,246
Costof sales 8,663 8,441 8,946 8,837 34,887 22% (27) 70 190 (742) (509)
Gross margin 29,330 29,823 33,595 33,622 126,370 78% 3,472 4,894 4,614 3,775 16,755
                       
Gross margin percentage 77.2% 77.9% 79.0% 79.2% 78.4%            
                       
SG&A expense 5,083 5,519 5,456 5,667 21,725 14% 132 618 750 848 2,348
R&D expense 4,963 5,450 5,082 5,278 20,773 13% 130 471 (204) (205) 192
Amortization expense 400 399 400 400 1,599 1% (84) (86) (85) (85) (340)
Interest expense 175 172 167 164 678 -- (148) (124) (11) (13) (296)
Interest income (726) (762) (853) (910) (3,251) (2%) 64 (58) (121) (203) (318)
Impairment loss on equity investment in DGI -- -- -- 1,523 1,523 1% -- -- -- 1,523 1,523
Othernon-operating exp., net 78 20 415 269 782 -- (72) 36 475 221 660
  9,973 10,798 10,667 12,391 43,829 27% 22 857 804 2,086 3,769
Earnings before income taxes 19,357 19,025 22,928 21,231 82,541 51% 3,450 4,037 3,810 1,689 12,986
Income taxes 6,785 6,655 8,309 7,864 29,613 18% 1,323 1,548 1,585 998 5,454
  12,572 12,370 14,619 13,367 52,928 33% 2,127 2,489 2,225 691 7,532
                       
Diluted earnings per share 0.30 0.30 0.35 0.32 1.27            
Weighted average diluted shares outstanding 41,600 41,653 41,752 41,785 41,697            
                       

Back to Top
HEMATOLOGY DIVISION
(in thousands of $’s)

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
  First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD Percent
Of Sales
First
Quarter
Second
Quarter
Third
Quartter
Fourth
Quarter
YTD
Sales 4,281 4,454 4,069 4,674 17,478 100% 507 468 72 (235) 812
Cost of sales 2,346 2,344 2,234 2,487 9,411 54% 209 232 53 113 607
Gross margin 1,935 2,110 1,835 2,187 8,067 46% 298 236 19 (348) 205
                       
Gross margin percentage 45.2% 47.4% 45.1% 46.8% 46.2%            
                       
SG&A expense 391 383 439 484 1,697 10% (9) 16 74 109 190
R&D expense 191 190 203 197 781 4% 18 (3) 4 (8) 11
Interest income (77) (74) (79) (82) (312) (2%) 24 9 8 0 41
  505 499 563 599 2,166 12% 33 22 86 101 242
Pretax result 1,430 1,611 1,272 1,588 5,901 34% 265 214 (67) (449) (37)

Back to Top
BIOTECHNOLOGY DIVISION
(in thousands of $’s)

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
  First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD Percent
Of Sales
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD
Sales 28,653 27,766 31,214 31,435 119,068 100% 2,016 2,811 2,697 2,449 9,973
Intersegment sales (4,621) (4,967) (5,145) (4,953) (19,686)   (471) (466) (270) (348) (1,555)
  24,032 22,799 26,069 26,482 99,382   1,545 2,345 2,427 2,101 8,418
                       
Cost of sales 5,916 5,530 6,121 5,774 23,341 20% 191 70 429 (292) 398
Intersegment sales (4,521) (4,894) (5,140) (4,897) (19,452)   (371) (411) (272) (290) (1,344)
  1,395 636 981 877 3,889   (180) (341) 157 (582) (946)
                       
Gross margin 22,637 22,163 25,088 25,605 95,493 80% 1,725 2,686 2,270 2,683 9,364
                       
Gross margin percentage 79.4% 80.1% 80.4% 81.6% 80.4%            
                       
SG&A expense 2,651 2,949 2,917 3,244 11,761 10% (61) 109 271 617 936
R&D expense 4,164 4,307 4,290 4,378 17,139 14% 201 180 127 8 516
Amortization expense 400 399 400 400 1,599 1% (84) (86) (85) (85) (340)
Interest income (406) (388) 411) (431) (1,636) (1%) 85 19 14 (28) 90
  6,809 7,267 7,196 7,591 28,863 24% 141 222 327 512 1,202
Pretax result 15,828 14,896 17,892 18,014 66,630 56% 1,584 2,464 1,943 2,171 8,162

Back to Top
R&D SYSTEMS EUROPE
(in thousands of £'s) 

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
  First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD Percent
Of Sales
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD
Sales 5,980 6,365 6,721 6,284 25,350 100% 663 732 397 56 1,848
Intersegment sales -- -- -- -- --   9 6 8 2 25
  5,980 6,365 6,721 6,284 25,350   672 738 405 58 1,873
                       
Cost of sales 3,040 3,157 3,107 3,022 12,326 49% (157) (203) (498) (505) 1,363)
Gross margin 2,940 3,208 3,614 3,262 13,024 51% 820 935 895 561 3,211
                       
Gross margin percentage 49.2% 50.4% 53.8% 51.9% 51.4%            
                       
SG&A expense 1,050 1,092 978 987 4,107 16% 17 101 13 (16) 115
Interest income (127) (150) (175) (202) (654) (3%) (23) (35) (60) (87) (205)
Exchange loss/(gain) (49) (73) 46 40 (36) -- (80) 6 171 91 188
  874 869 849 825 3,417 13% (86) 72 124 (12) 98
Pretax result 2,066 2,339 2,765 2,437 9,607 38% 906 863 771 573 3,113

Back to Top
R&D SYSTEMS EUROPE
(in thousands of $’s)

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
  First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD Percent
Of Sales
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD
Sales 9,680 11,011 12,403 11,303 44,397 100% 1,379 2,142 2,291 1,164 6,976
Intersegment sales -- -- -- -- --   14 9 14 3 40
9,680 11,011 12,403 11,303 44,397   1,393 2,151 2,305 1,167 7,016
                     
Cost of sales 4,922 5,461 5,731 5,473 21,587 49% (70) 170 (34) (276) (210)
Gross margin 4,758 5,550 6,672 5,830 22,810 51% 1,449 1,972 2,325 1,440 7,186
                     
Gross margin percentage 49.2% 50.4% 53.8% 51.6% 51.4%            
                     
SG&A expense 1,699 1,891 1,805 1,799 7,194 16% 87 328 261 163 839
Interest income (206) (260) (323) (357) (1,146) (3%) (43) (80) (138) (171) (432)
Exchange loss/(gain) (84) (129) 85 65 (63) -- (133) (1) 285 142 293
1,409 1,502 1,567 1,507 5,985 13% (89) 247 408 134 700
Pretax result 3,349 4,048 5,105 4,323 16,825 38% 1,538 1,725 1,917 1,306 6,486

Back to Top
CORPORATE AND OTHER (1)
(in thousands of $’s)

  Fiscal 2004 Increase(Decrease) From Fiscal 2003
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
YTD
Interest income 37 40 40 40 157 2 6 5 4 17
Rental income 19 46 20 47 132 19 40 1 0 60
  56 86 60 87 289 21 46 6 4 77
                     
SG&A expense 342 296 295 140 1,073 115 165 144 (41) 383